NAT2 and myopia: Given that TGF-βs are key regulators of vascular function [51] and choroidal vascular dysfunction is a well-established contributor to myopia pathogenesis [52], we sought to investigate whether ECM derived from NAT2-altered scleral fibroblasts could influence choroidal vascular function.